Raymon Heather K

Pharmacology Bristol Myers Squibb

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 73 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Data from Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies

Emanuela Dylgjeri,Christopher McNair,Jonathan F. Goodwin,Heather K. Raymon, Peter A. McCue,Ayesha A. Shafi,Benjamin E. Leiby,Renée de Leeuw,Vishal Kothari,Jennifer J. McCann,Amy C. Mandigo,Saswati N. Chand,Matthew J. Schiewer,Lucas J. Brand,Irina Vasilevskaya,Nicolas Gordon,Talya S. Laufer,Leonard G. Gomella,Costas D. Lallas,Edouard J. Trabulsi,Felix Y. Feng,Ellen H. Filvaroff,Kristin Hege,Dana Rathkopf,Karen E. Knudsen

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure 5 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

Beatrice Gini,Ciro Zanca,Deliang Guo,Tomoo Matsutani,Kenta Masui,Shiro Ikegami,Huijun Yang,David Nathanson,Genaro R. Villa,David Shackelford,Shaojun Zhu,Kazuhiro Tanaka,Ivan Babic,David Akhavan,Kelly Lin,Alvaro Assuncao,Yuchao Gu,Bruno Bonetti,Deborah S. Mortensen,Shuichan Xu,Heather K. Raymon,Webster K. Cavenee,Frank B. Furnari,C. David James,Guido Kroemer,James R. Heath,Kristen Hege,Rajesh Chopra,Timothy F. Cloughesy,Paul S. Mischel

crossref（2023）

Cited0Views0Bibtex

Structure-based Optimization of Aminothiadiazole Inhibitors of AKT

Deborah S. Mortensen,Sayee G. Hegde,Sophie M. Perrin-Ninkovic,Sogole Bahmanyar,Meg McCarrick,Roy Harris,Robert Hilgraf,Branden G. S. Lee,Jeff McKie,Lisa Nadolny,John Sapienza,Alice Collette,Sarah Cox,James C. Gamez,Jennifer L. Hensel, Xuequn Helen Hua,Jim Leisten,Heather K. Raymon,Tam Tran,Rama Krishna Narla

Medicinal Chemistry Research（2023）

Cited0Views0Bibtex

Supplementary Figure 4 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure 6 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

crossref（2023）

Cited0Views0Bibtex

Data from CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization

Deborah S. Mortensen,Kimberly E. Fultz,Shuichan Xu,Weiming Xu,Garrick Packard,Godrej Khambatta,James C. Gamez,Jim Leisten,Jingjing Zhao,Julius Apuy,Kamran Ghoreishi,Matt Hickman,Rama Krishna Narla,Rene Bissonette,Samantha Richardson,Sophie X. Peng,Sophie Perrin-Ninkovic,Tam Tran,Tao Shi,Wen Qing Yang,Zeen Tong,Brian E. Cathers,Mehran F. Moghaddam,Stacie S. Canan,Peter Worland,Sabita Sankar,Heather K. Raymon

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure 7 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

crossref（2023）

Cited0Views0Bibtex

Supplemental Methods; Supplemental Tables S1-S7; and Supplemental Figures S1-S6 from Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK1/2 Inhibitor for Treatment of Triple-Negative Breast Cancer with a Compromised G<sub>1</sub>–S Checkpoint

Daiyin Zhu,Shuichan Xu,Gordafaried Deyanat‐Yazdi,Sophie X. Peng,Leo A. Barnes,Rama Krishna Narla,Tam Tran,David Mikolon,Yuhong Ning,Tao Shi,Jing Ning,Heather K. Raymon,Jennifer R. Riggs, John F. Boylan

openalex

Cited0Views0Bibtex

Supplementary Figure 5 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

crossref（2023）

Cited0Views0Bibtex

Supplementary Tables from Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies

openalex（2023）

Cited0Views0Bibtex

Author Statistics

#Papers: 75

#Citation: 1744

H-Index: 23

G-Index: 41

Sociability: 6

Diversity: 2

Activity: 4

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn